SYNOPSIS It has been shown that the incidence of megaloblastic anaemia in a group of 463 randomly selected pregnant women receiving iron was 12 times as high as in a control group of 235 pregnant women receiving iron and folic acid. The incidence of all types of anaemia in the women receiving iron alone was more than three times the incidence in those having iron and folic acid. Some women who were not anaemic or who had normoblastic anaemia had serum folate levels in the same range as the women with megaloblastic anaemia, but none of the women with megaloblastic anaemia had high serum folate levels. The labile fraction of the serum folate was no more reliable than the total serum folate as a diagnostic criterion of megaloblastic crythropoiesis in the individual case. The blood group distribution in the women with megaloblastic anaemia was the same as in the general population. Babies born to mothers with megaloblastic anaemia tended to be smaller than the rest, although there was no difference in the placental weights.
Megaloblastic erythropoiesis, with a varying degree of anaemia, is now known to be common in pregnancy. Although erythropoiesis is restored to normal by folic acid, estimation of the total serum folate is not a reliable guide to diagnosis, as it is in other folate-deficiency states such as steatorrhoea. It has been claimed that the level of the labile fraction of the serum folate (probably 5-methyl-tetrahydrofolic acid) is a reliable diagnostic criterion (Ball and Giles, 1964; Giles, 1966) . If this is so, then an important factor in the pathogenesis of megaloblastic anaemia of pregnancy would seem to be an inability to metabolize folate compounds to their most useful form.
There have been conflicting reports about the incidence of serious complications such as toxaemia, abortion, antepartum haemorrhage, and premature labour in pregnant women with megaloblastic anaemia (Gatenby and Lillie, iPresent address: Mill Road Maternity Hospital, Liverpool Received for publication 21 October 1969. 1960; Mackenzie and Abbott, 1960; Hibbard and Hibbard, 1963; Martin, Harper, and Kelso, 1965; Giles, 1966) .
Some workers have found an abnormally high incidence of blood group A in megaloblastic anaemia of pregnancy, and this has been taken to support the suggestion that a predisposition to the condition may be inherited (Giles, 1966) .
We embarked on the work reported here to find out (1) whether the incidence of megaloblastic anaemia of pregnancy was as high in north Liverpool as in other similar industrial areas; (2) whether, in the patients not prescribed folic acid, the labile fraction of the serum folate was a more satisfactory diagnostic criterion of megaloblastic anaemia than the total serum folate; (3) whether, in north Liverpool, megaloblastic anaemia of pregnancy was associated with other serious complications of pregnancy, and (4) whether there was an abnormally high incidence of blood group A in our patients with megaloblastic anaemia of pregnancy.
Material and Methods
The catchment area served by the hospital in which this work was carried out is highly industrial. The patients are almost exclusively from social classes IV and V. There is a high proportion of Roman Catholics in the area which is, in part, responsible for the prevalence of grand multiparity amongst the patients. Obesity and poor dietary habits are common. Many patients exist on a diet consisting largely of carbohydrates with very little protein and fat. It is not unusual for a well balanced meal to be taken only once a week, and for the favourite meals at other times to consist of a chip sandwich and a cup of tea.
In spite of the low social class of most of the patients the economic status is often unexpectedly high, because of the nature of the work which is available locally and the high earning capacity of the large family units. 
COLLECTION OF BLOOD AND MARROW
Samples ofvenous blood were taken from patients in both groups at the first visit to the antenatal clinic, at the 32nd and 36th weeks of pregnancy, and during the first three days of the puerperium. Serum from the patients who did not take folic acid was stored (see below) for possible folate estimations. Total and labile serum folate levels were estimated in the patients whose marrows were examined (see below) and in some 'nonanaemic' patients selected at random from those not receiving folic acid. Folate studies were not made on serum collected from patients who did take folic acid.
Blood from all patients in both groups was examined for haemoglobin concentration within 24 hours of collection. If the concentration was below the arbitrarily chosen level of 10-9 g per 100 ml, the sternal marrow was examined. If erythropoiesis proved to be megaloblastic, folic acid was prescribed for the remainder of the pregnancy; if erythropoiesis was normoblastic, oral or parenteral iron was given.
Folate estimations were also made in some patients who were not in either of our two trial groups, but were discovered to have megaloblastic anaemia of pregnancy while the investigation was in progress. We did not, of course, have serum for folate estimation taken at earlier stages of pregnancy in these patients, and they were not included in our assessment of the incidence of the disease nor of the complications associated with it.
CLASSIFICATION OF PATIENTS
Patients with a haemoglobin concentration of 10-9 g per 100 ml or more were classified 'not anaemic', and those with a haemoglobin concentration of under 10-9 g per 100 ml were classified 'normoblastic' or 'megaloblastic' according to the marrow smear. The megaloblastic group was further subdivided into grade 3 (floridly megaloblastic), grade 2 (true megaloblasts present but erythropoiesis largely normoblastic), or grade 1 (no true megaloblasts, but at least two of the following features, namely, transitional megaloblasts, macronormoblasts, Howell-Jolly bodies in some of the red cell precursors, giant metamyelocytes). A further group of 'unclassified' patients comprised 45 women with a haemoglobin level of under 10-9 g per 100 ml, whose sternal marrow was not, for various reasons, examined.
In an attempt to overcome bias in interpreting marrow smears, we adopted the following procedure. The marrow smears were examined at once, since the patient's management depended on the result. All smears were then taken and stored by a secretary, who gave each a code number. Months later, at the end of the trial, all the coded smears were graded by one of us (P.M.R.), the patient's name being unknownto the microscopist. Approximately eight weeks later, the coded smears were re-examined by P.M.R. without reference to the grade given at the first examination. The gradings from the two examinations were then compared, the patient's identity remaining unknown. After the lapse of several more weeks, the few smears where the two gradings had not coincided were again examined and regraded. The final grading was that given on at least two occasions. Not till after the final grading was given was the code broken and the patient's name matched to the smear.
LABORATORY TECHNIQUES
Venous specimens were used for the haemoglobin estimation,whichwas done by the cyanmethaemoglobin technique.
We used Lactobacillus casei for assaying the serum folate. Our method was based on that of Spray (1964) with some modifications. Cowan, Hoffbrand, and Mollin (1966) showed that serum extracts enhance the growth of Lactobacillus casei more than can be accounted for by the folate content of the extracts. Our own experiments confirmed this and showed that the non-specific growth-enhancing effect was less when high dilutions of serum extract were used, and less after a long (40 hours) than after a short (18 hours) incubation period. We therefore used high dilutions of serum extract (1/96 and 1/92) and an incubation period of 40 hours. To reduce the contamination of the unknown serum by folate carried in or on the lactobacilli, the organisms were depleted of folate by being grown in a folate-free medium for five to six hours before the assay. These features of our method resulted in lower overall values than have been found by some other workers. (Our range of normal for healthy non-pregnant young women is 1'3-8-5 ng/ml total serum folate, with a geometric mean of 3-3 ng/ml and an arithmetic mean of 3-6 ng/ml). Full details of our assay method are given in the Appendix.
Results

INCIDENCE OF ANAEMIA
As shown in Table I , the incidence of anaemia of all kinds was more than three times higher (146 patients, 31-5 %) in women taking iron alone than it was in those taking both iron and folic acid (23 patients, 9-8 %). Megaloblastic erythropoiesis was found in 42 patients (9 1 %) who did not take folic acid, and in two for whom folic acid had Included in the 146 patients (31-5 %) who were anaemic are 45 patients (9-7 %) whose marrows were not examined. It is likely that some of these women may have had megaloblastic anaemia, so that the true incidence of this condition may have been even higher than 9-1 %.
TIME OF ONSET OF ANAEMIA
Our results confirm those of other workers who demonstrated that megaloblastic anaemia is more likely to occur as pregnancy advances (Hibbard and Hibbard, 1968) . Thirty-three (80%) of our patients with megaloblastic anaemia developed the condition in the third trimester and a further six (14%) in the puerperium.
SEVERITY OF ANAEMIA
None of our patients with normoblastic anaemia had a haemoglobin concentration of less than 7-25 g per 100 ml at any stage of pregnancy or the puerperium. However, of eight patients with grade 2 or 3 megaloblastic erythropoiesis, three (37-5 %) had a haemoglobin concentration of less than 7 27 g per 100 ml.
In general, we found that as erythropoiesis became more megaloblastic, so did the severity of the anaemia increase.
In the 23 patients prescribed iron and folic acid who did become anaemic the lowest haemoglobin concentration discovered was 8 45 g per 100 ml.
TOTAL AND LABILE SERUM FOLATE LEVELS AT DIFFERENT STAGES OF PREGNANCY AND IN THE THREE HAEMOPOIETIC GROUPS
In the non-anaemic group, the geometric mean of the total and labile folates was higher in the second than in the first trimester; apart from this, the geometric mean of the folate levels in all three groups fell as pregnancy advanced (Figs. la and lb).
From the second trimester onwards the geometric mean of the total serum folate levels was highest in the non-anaemic group, lower in the normoblastic group, and lower still in the megaloblastic group (Fig. la) . The numbers of firsttrimester specimens available for folate estimation in the normoblastic and megaloblastic groups were small (five normoblastic and three megaloblastic), so thatwe cannot attach much significance to the first trimester geometric means in these groups. While there was, from the second trimester onwards, a correlation between the haemoglobin level and type of anaemia on the NA one hand, and the geometric mean of the total serum folates on the other, there was much overlap between the serum folate levels in the three haemopoietic groups (Figs. 2a, 2b, 2c, and 2d) .
The labile serum folate followed much the same pattern as the total serum folates (Figs. lb,  3a, 3b, 3c, 3d) . Megaloblastic ( Range 0.5 -7.6
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Fig. 3b Fig. 3a, 3b , 3c, and 3d Labile serum folates in the various stages ofpregnancy, grouped according to type of erythropoiesis. 3a = first trimester, 3b = second trimester, 3c = third trimester, 3d = puerperium. ('Normoblastic' and 'megaloblastic' refer to the patient's eventual classification; she did not necessarily have normoblastic (or megaloblastic) anaemia at the time the sample was taken.) Dotted line represents the geometric mean. As the diagram does not go above 6 ng values above this level are marked at 6 with the actual level written above the dot. Figs. 5a and 5b Total (Sa) and labile (Sb) serum folates in the third trimester, grouped according to type of erythropoiesis, using only the sera taken at the same time as the marrow was aspirated. Dotted line represents the geometric mean.
anaemia is an earlier manifestation of folate lack and that if this lack continues long enough, megaloblastic anaemia will develop. (Giles, 1960 Collection of serum Venous blood was taken into specially washed Becton-Dixon Vacutainers; the serum was separated within a few hours of its collection and divided equally between two plastic disposable bottles, ascorbic acid (5 mg/ml) being added to one but not the other; the paired sera were stored at 20°C, and the two members of the pair were assayed at the same time. The labile fraction was calculated by subtracting the stable fraction (estimated by assay of the serum without added ascorbic acid) from the total serum folate (estimated by assay of the serum with added ascorbic acid). Standardfolic acid solution Pteroylglutamic acid (Lederle) was made into a 1 mg/ml solution by the method described by Dacie and Lewis (1963) .
Assay medium
Preparation ofserum extracts
Of the serum to be tested, 0 5 ml was added to 4-5 ml of 0-1M sodium phosphate buffer pH 6-1. Ascorbic acid, 150 mg0%, was added to the buffer when the total serum folate was to be assayed but not when the labile fraction was to be estimated. The solution was autoclaved for two and a half minutes at 15 lb psi, cooled, and 11 ml distilled water added to it (making 1/32 dilution of serum). After mixing by gentle inversion, the solution was centrifuged to precipitate the proteins, and the clear extract was decanted ready for assay.
Assays were carried out in 5 x i in. test tubes and were performed in duplicate at two dilutions of each test serum, I ml of serum extract plus 1 ml of distilled water being placed in each of two tubes and 2 ml of serum extract with no distilled water in the remaining two. (Svendmyr pipetting syringes set at 1 ml were used.) Preparation of standards A stock standard solution of pteroylglutamic acid (Lederle), 1 mg/ml, was made up by the method described by Dacie et al (1963) . This was serially diluted in distilled water to give a dilution of 1 ng. From this, six working standards were prepared by serial doubling dilution in distilled water, so that the final standards contained respectively 1-0, 0-5, 0-25, 0-125, 0-06, and 0-03 millimicrograms of pteroylglutamic acid. One ml of each working standard was then placed in each of three tubes, and 1 ml of distilled water added; each standard dilution was thus set up in triplicate.
Six blanks were also set up, each containing 2 ml distilled water.
Addition ofmedium
Four ml of assay medium was added to the test sera, standards, and 'blanks', which were all then autoclaved for 5 min at 15 lb psi.
Inoculation and incubation When the tests, standards, and blanks had cooled after autoclaving, they were all (except one set of three blanks) inoculated with 1 drop of the bacterial suspension. All were then incubated for 40 hours at 37°C. Two ml 10% HC1 was added to each tube, and the turbidity of each suspension was read in a nephalometer.
Preparation ofbacterial suspension Lactobacillus casei (obtained from Scientific
Hospital Supplies Ltd, Liverpool), was maintained in stab cultures of Difco micro-assay culture agar (B.319) and regularly subcultured in Difco micro-inoculum broth (B.320). One such subculture was incubated overnight before the assay; on the morning of the asasy,15 ml of folatefree assay medium was inoculated with one small platinum loop of the subculture, incubated at 37°C for five to six hours, and used to inoculate tests and standards.
Reading the assays The turbidity of the solution in the six standard tubes was read in the nephalometer. A graph was then constructed, with pteroylglutamic acid concentration along one axis and bacterial growth (as reflected in turbidity) along the other. This standard curve was used to read off the folate concentrations of the test sera.
